On April 29, CHINA STARCH (03838) spent 25,200 Hong Kong dollars to repurchase 135,000 shares.
China Starch (03838) announced that on April 29, 2026, the company spent 25,200 Hong Kong dollars to repurchase 135,000 shares, at a repurchase price of 0.185-0.187 Hong Kong dollars per share.
China Starch (03838) announced that on April 29, 2026, the company will spend HKD 25,200 to repurchase 135,000 shares at a repurchase price of HKD 0.185-0.187 per share.
Related Articles
STERLING GP (01825) appoints Zhang Yuan as an independent non-executive director.
JINGCHENG MAC (00187) released its first-quarter financial results, with a net loss attributable to shareholders of approximately 32.21 million yuan, an increase of about 1.7 times year-on-year.
HUTCHMED (00013): Sovleplenib, a Chinese new drug used to treat warm antibody type autoimmune hemolytic anemia patients, has received acceptance for market application and has been included in priority review and breakthrough therapy varieties.
STERLING GP (01825) appoints Zhang Yuan as an independent non-executive director.
JINGCHENG MAC (00187) released its first-quarter financial results, with a net loss attributable to shareholders of approximately 32.21 million yuan, an increase of about 1.7 times year-on-year.
HUTCHMED (00013): Sovleplenib, a Chinese new drug used to treat warm antibody type autoimmune hemolytic anemia patients, has received acceptance for market application and has been included in priority review and breakthrough therapy varieties.
RECOMMEND
